|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.736 USD | -3.60% |
|
-5.35% | +0.28% |
MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM) entered into a memorandum of understanding to acquire Japan Gene Medicine Corporation for ¥2.4 billion on March 29, 2024. The MOU was executed on April 2, 2024. The deal is subject to consummation of due diligence.
Definitive agreement is expected to be signed on May 31, 2024 , and the deal is expected to be completed on June 30, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.28% | 29.05M | |
| +6.38% | 10.51B | |
| -11.40% | 2.48B | |
| -11.07% | 2.42B | |
| -21.35% | 2.19B | |
| -0.09% | 1.98B | |
| -2.51% | 998M | |
| -11.51% | 967M | |
| -37.09% | 760M | |
| 0.00% | 672M |
MEDIROM HEALTHCARE TECHNOLOGIES INC. 
